New Trial of Personalized Cancer Treatment Begins in Oxford|
Tuesday, March 18, 2014
Phase I trial in Oxford will investigate a new drug, called CXD101.
Purdue, Houston Methodist to Take Drug Discoveries from the Bench Top to the Bedside
Monday, March 17, 2014
The planned collaboration on research and educational initiatives includes clinical trials of drugs developed at Purdue.
Charles River to Acquire Argenta and BioFocus from Galapagos
Thursday, March 13, 2014
Capabilities of companies' more than 340 scientists will augment Charles River’s position.
Argenta, Antabio Achieve Milestone in Anti-bacterial Drug Discovery Collaboration
Monday, March 10, 2014
Argenta has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug discovery project funded by the Wellcome Trust.
Codexis Appoints Patrick Yang to Board of Directors
Friday, February 28, 2014
Dr. Yang brings significant experience in pharmaceutical manufacturing and process development.
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
Thursday, February 27, 2014
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.
Reviewing Colchicaceae Alkaloids - Perspectives of Evolution on Medicinal Chemistry
Monday, February 24, 2014
Researchers have shown how thinking about evolution can influence selection of plant material in drug lead discovery.
Nuevolution, Merck License Agreement
Friday, February 21, 2014
Agreement for small molecule compounds targeting an undisclosed intracellular target for use as leads in Merck’s drug discovery and development.
Proteros Elects New Supervisory Board Member
Thursday, February 20, 2014
Shareholders confirmed the appointment of Prof. Eric-Paul Pâques as a new member of the Supervisory Board.